Tyra Biosciences Dividends

TYRA Stock  USD 31.33  1.93  6.56%   
As of February 20, 2026, Dividend Paid And Capex Coverage Ratio is expected to decline to -126.89. Tyra Biosciences' past performance could be the main factor of why investors trade Tyra Biosciences stock today. Investors should clearly understand every aspect of the Tyra Biosciences dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Tyra Biosciences' dividend schedule and payout information. Tyra Biosciences dividends can also provide a clue to the current valuation of Tyra Biosciences.
Last ReportedProjected for Next Year
Dividend Paid And Capex Coverage Ratio(120.84)(126.89)
One of the primary advantages of investing in dividend-paying companies such as Tyra Biosciences is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive.
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Tyra Biosciences must own a stock before its ex-dividend date to receive its next dividend.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tyra Biosciences. If investors know Tyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Tyra Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(1.88)
Return On Assets
(0.23)
Return On Equity
(0.35)
Understanding Tyra Biosciences requires distinguishing between market price and book value, where the latter reflects Tyra's accounting equity. The concept of intrinsic value - what Tyra Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Tyra Biosciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between Tyra Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tyra Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Tyra Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Compare Dividends Across Peers

Specify up to 10 symbols: